Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
CH-4051 in active rheumatoid arthritis (MOTION)
NCT01116141Phase 2Completed
- Sponsor
- Chelsea Therapeutics International, Ltd.
- Start
- Sep 2010
- Primary completion
- Apr 2012
01
Overview
A Phase 2 trial of CH-4051 in rheumatoid arthritis (RA), sponsored by Chelsea Therapeutics International, Ltd.. Started Sep 2010; status: completed.
02
Drugs
CH-4051
03
Conditions
rheumatoid arthritis (RA)
Beyond the preview
Go deeper on NCT01116141.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01116141.